Nadroparin calcium
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
ATC code | B01AB06 |
Chemical data | |
Formula | ? |
Mol. mass | 4500 Daltons on average |
(what is this?) (verify) | |
Nadroparin is a form of low molecular weight heparin sold by GSK under the trade name Fraxiparine.[1]
References
- ↑ GSK PRODUCT MONOGRAPH; http://www.gsk.ca/english/docs-pdf/Fraxiparine_2011.pdf
External links
- http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=483128
- http://www.mayoclinic.com/health/drug-information/DR600971
- Shafiq N, Malhotra S, Pandhi P, Sharma N, Bhalla A, Grover A (2006). "A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study". Pharmacology 78 (3): 136–43. doi:10.1159/000096484. PMID 17057417.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.